Toxicity Evaluation of Replication-Competent Herpes Simplex Virus (ICP 34.5 Null Mutant 1716) in Patients With Recurrent Malignant Glioma

Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3301184